Cecelia Smith Schoenwalder - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Cecelia Smith Schoenwalder's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Cecelia Smith Schoenwalder
Verified
Science and Environment Writer, U.S. News and World Report
Washington
Beats
Spirits, beer
Content
By Cecelia Smith Schoenwalder Verified| U.S. News and World Report Verified The Food and Drug Administration this week approved a new type of painkiller that doesn’t carry the risk of addiction or overdose associated with opioid medications. The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
By Cecelia Smith Schoenwalder Verified| U.S. News and World Report Verified Robert F. Kennedy Jr. faced his second Senate confirmation hearing in as many days on Thursday as he navigated questions from lawmakers who are vetting him for the job of Department of Health and Human Services secretary. President Donald Trump’s pick to lead HHS faced many of the same topics brought up the day before, including his flip-flopping stance on abortion and past statements on vaccines. Senators also questioned him on Medicare and Medicaid.
By Cecelia Smith Schoenwalder Verified| U.S. News and World Report Verified The Food and Drug Administration this week approved a new type of painkiller that doesn’t carry the risk of addiction or overdose associated with opioid medications. The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
Company Info
U.S. News and World Report
Washington, District of Columbia, United States
+1 202-955-2000